Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Director at Avalo Therapeutics (AVTX) gains 3,166 common shares
Avalo Therapeutics Director Jonathan Goldman exercised 3,166 restricted stock units (RSUs) into common shares on March 28, 2026, at an exercise price of $0.00 per share. This transaction resulted from the vesting of a portion of 9,500 RSUs granted to him on August 13, 2024, contingent on his continued service. The Form 4 filing indicates this was a derivative exercise, not an open-market purchase or sale.